Vanderbilt Institute for Clinical and Translational Research (VICTR) Archive — Page 2 of 7
-
May 4, 2023
VUMC to coordinate national effort to reduce ARDS, pneumonia, sepsis
Vanderbilt University Medical Center has received a $31.6 million federal grant to lead a national effort to better understand acute respiratory distress syndrome, pneumonia and sepsis. -
April 11, 2023
VUMC-led trial shows two investigational drugs are ineffective for treating severe COVID-19
A Vanderbilt-led study evaluating two investigational drugs to treat severe COVID-19 demonstrated that neither drug was effective. -
April 6, 2023
Research Staff Awards honor contributions to discovery
-
January 26, 2023
VUMC establishes novel Center for Learning Healthcare
Vanderbilt University Medical Center has established a first-of-its-kind Center for Learning Healthcare that will bring together clinicians, health system operations leaders and researchers to generate evidence in the course of health care delivery to continuously improve the quality, value and safety of health care offered to patients. -
December 16, 2022
VUMC Announces VICTR Leadership Transition
-
November 10, 2022
Clinical trial at VUMC tests novel treatment for asthma
VUMC has begun enrolling patients with asthma in a clinical trial of a novel treatment: a medication approved to treat diabetes and obesity. -
October 6, 2022
VUMC to test whether Alzheimer’s drug can ease lupus symptoms
Vanderbilt University Medical Center is partnering with Evergreen Therapeutics Inc. to test whether an Alzheimer’s drug, memantine, can improve cognitive symptoms associated with systemic lupus.